GB1508169A - Substituted cyclopenta(b)furan compounds useful in the synthesis of prostaglandin analogues - Google Patents
Substituted cyclopenta(b)furan compounds useful in the synthesis of prostaglandin analoguesInfo
- Publication number
- GB1508169A GB1508169A GB29060/77A GB2906077A GB1508169A GB 1508169 A GB1508169 A GB 1508169A GB 29060/77 A GB29060/77 A GB 29060/77A GB 2906077 A GB2906077 A GB 2906077A GB 1508169 A GB1508169 A GB 1508169A
- Authority
- GB
- United Kingdom
- Prior art keywords
- phenyl
- thienyl
- formula
- cyclopenta
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- XSDLSEOIVCVTQZ-UHFFFAOYSA-N 2h-cyclopenta[b]furan Chemical class C1=CC2=CCOC2=C1 XSDLSEOIVCVTQZ-UHFFFAOYSA-N 0.000 title abstract 3
- 229940006138 antiglaucoma drug and miotics prostaglandin analogues Drugs 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- -1 tropanyl Chemical group 0.000 abstract 5
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 abstract 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 abstract 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 abstract 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 abstract 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- VONWDASPFIQPDY-UHFFFAOYSA-N dimethyl methylphosphonate Chemical compound COP(C)(=O)OC VONWDASPFIQPDY-UHFFFAOYSA-N 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000004702 methyl esters Chemical class 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53167674A | 1974-12-11 | 1974-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1508169A true GB1508169A (en) | 1978-04-19 |
Family
ID=24118594
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB29060/77A Expired GB1508169A (en) | 1974-12-11 | 1975-12-10 | Substituted cyclopenta(b)furan compounds useful in the synthesis of prostaglandin analogues |
| GB29061/77A Expired GB1508170A (en) | 1974-12-11 | 1975-12-10 | Substituted cyclopentane compounds useful as intermediates in the synthesis of prostaglandin analogues |
| GB50700/75A Expired GB1508168A (en) | 1974-12-11 | 1975-12-10 | 11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB29061/77A Expired GB1508170A (en) | 1974-12-11 | 1975-12-10 | Substituted cyclopentane compounds useful as intermediates in the synthesis of prostaglandin analogues |
| GB50700/75A Expired GB1508168A (en) | 1974-12-11 | 1975-12-10 | 11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins |
Country Status (21)
| Country | Link |
|---|---|
| JP (3) | JPS51125257A (no) |
| AT (1) | AT351185B (no) |
| BE (1) | BE836564A (no) |
| CH (1) | CH610302A5 (no) |
| CS (3) | CS194746B2 (no) |
| DD (3) | DD125828A5 (no) |
| DE (1) | DE2555210A1 (no) |
| DK (1) | DK559975A (no) |
| ES (1) | ES443421A1 (no) |
| FI (1) | FI753475A (no) |
| FR (1) | FR2293923A1 (no) |
| GB (3) | GB1508169A (no) |
| GR (1) | GR60310B (no) |
| IE (1) | IE43815B1 (no) |
| IL (2) | IL48617A0 (no) |
| LU (1) | LU73997A1 (no) |
| NL (1) | NL166015C (no) |
| NO (1) | NO754195L (no) |
| NZ (1) | NZ179502A (no) |
| SE (1) | SE7513602L (no) |
| ZA (1) | ZA747723B (no) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9284252B2 (en) | 2009-06-09 | 2016-03-15 | Sepal Pharma Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
| US9284274B2 (en) | 2005-12-07 | 2016-03-15 | Ramot At Tel-Aviv University Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486540A (en) * | 1993-10-28 | 1996-01-23 | Allergan, Inc. | Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents |
| KR20010074981A (ko) | 1998-09-14 | 2001-08-09 | 우에노 도시오 | ω치환된 페닐프로스타그란딘 Ｅ 유도체 및 그 유도체를유효 성분으로 하는 약제 |
| ES2576980T3 (es) * | 2005-12-07 | 2016-07-12 | Ramot At Tel Aviv University, Ltd. | Derivados químicos de jasmonato, composiciones farmacéuticas y métodos de uso de los mismos |
| CN104640542B (zh) | 2012-07-19 | 2017-09-22 | 开曼化学股份有限公司 | 用于ep4介导的骨相关疾病和病症的二氟内酰胺组合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES416865A1 (es) * | 1972-07-13 | 1976-03-01 | Pfizer | Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15. |
-
1974
- 1974-12-04 ZA ZA747723A patent/ZA747723B/xx unknown
-
1975
- 1975-11-11 GR GR49337A patent/GR60310B/el unknown
- 1975-12-02 SE SE7513602A patent/SE7513602L/xx unknown
- 1975-12-03 IE IE2635/75A patent/IE43815B1/en unknown
- 1975-12-08 IL IL48617A patent/IL48617A0/xx unknown
- 1975-12-09 DE DE19752555210 patent/DE2555210A1/de active Pending
- 1975-12-10 GB GB29060/77A patent/GB1508169A/en not_active Expired
- 1975-12-10 GB GB29061/77A patent/GB1508170A/en not_active Expired
- 1975-12-10 DK DK559975A patent/DK559975A/da not_active Application Discontinuation
- 1975-12-10 GB GB50700/75A patent/GB1508168A/en not_active Expired
- 1975-12-10 NZ NZ179502A patent/NZ179502A/xx unknown
- 1975-12-10 FI FI753475A patent/FI753475A/fi not_active Application Discontinuation
- 1975-12-10 NO NO754195A patent/NO754195L/no unknown
- 1975-12-11 JP JP50148319A patent/JPS51125257A/ja active Pending
- 1975-12-11 CS CS771242A patent/CS194746B2/cs unknown
- 1975-12-11 CS CS758428A patent/CS194733B2/cs unknown
- 1975-12-11 NL NL7514446.A patent/NL166015C/xx not_active IP Right Cessation
- 1975-12-11 AT AT941675A patent/AT351185B/de not_active IP Right Cessation
- 1975-12-11 CS CS771241A patent/CS194745B2/cs unknown
- 1975-12-11 ES ES443421A patent/ES443421A1/es not_active Expired
- 1975-12-11 LU LU73997A patent/LU73997A1/xx unknown
- 1975-12-11 DD DD190054A patent/DD125828A5/xx unknown
- 1975-12-11 DD DD7500197926A patent/DD129649A5/xx unknown
- 1975-12-11 BE BE1007076A patent/BE836564A/xx not_active IP Right Cessation
- 1975-12-11 DD DD7500197925A patent/DD129783A5/xx unknown
- 1975-12-11 CH CH1610875A patent/CH610302A5/xx not_active IP Right Cessation
- 1975-12-11 FR FR7537944A patent/FR2293923A1/fr active Granted
-
1977
- 1977-03-11 JP JP2687577A patent/JPS52102258A/ja active Pending
- 1977-03-11 JP JP2687477A patent/JPS52102270A/ja active Pending
-
1979
- 1979-03-13 IL IL56863A patent/IL56863A0/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9284274B2 (en) | 2005-12-07 | 2016-03-15 | Ramot At Tel-Aviv University Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| US9284252B2 (en) | 2009-06-09 | 2016-03-15 | Sepal Pharma Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
Also Published As
| Publication number | Publication date |
|---|---|
| CS194745B2 (en) | 1979-12-31 |
| IE43815L (en) | 1976-06-11 |
| GB1508170A (en) | 1978-04-19 |
| JPS52102270A (en) | 1977-08-27 |
| BE836564A (fr) | 1976-06-11 |
| LU73997A1 (no) | 1976-11-11 |
| AU8736275A (en) | 1977-10-13 |
| DD125828A5 (no) | 1977-05-18 |
| GR60310B (en) | 1978-05-08 |
| CH610302A5 (en) | 1979-04-12 |
| CS194746B2 (en) | 1979-12-31 |
| DD129649A5 (de) | 1978-02-01 |
| NO754195L (no) | 1976-06-14 |
| JPS51125257A (en) | 1976-11-01 |
| NL7514446A (nl) | 1976-06-15 |
| GB1508168A (en) | 1978-04-19 |
| DK559975A (da) | 1976-06-12 |
| IE43815B1 (en) | 1981-06-03 |
| NL166015B (nl) | 1981-01-15 |
| JPS52102258A (en) | 1977-08-27 |
| AT351185B (de) | 1979-07-10 |
| DE2555210A1 (de) | 1976-06-16 |
| ZA747723B (en) | 1976-11-24 |
| FR2293923B1 (no) | 1979-02-23 |
| SE7513602L (sv) | 1976-06-14 |
| ATA941675A (de) | 1978-12-15 |
| NZ179502A (en) | 1979-01-11 |
| IL48617A0 (en) | 1976-02-29 |
| ES443421A1 (es) | 1977-04-16 |
| IL56863A0 (en) | 1979-05-31 |
| FI753475A (no) | 1976-06-12 |
| NL166015C (nl) | 1981-06-15 |
| DD129783A5 (de) | 1978-02-08 |
| FR2293923A1 (fr) | 1976-07-09 |
| CS194733B2 (en) | 1979-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1515414A (en) | 2 descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanorprostaglandins | |
| US4161605A (en) | ω-Aryl-cis-13-PGE compounds | |
| US4082784A (en) | Cis-13-PGD1 compounds | |
| US4097508A (en) | Cis-4,5-didehydro-13,14 dihydro-9, dioxy PGF compounds | |
| US4124613A (en) | 9-Deoxy-PGD1 compounds | |
| IE781857L (en) | Prostaglandin analogues | |
| GB1508169A (en) | Substituted cyclopenta(b)furan compounds useful in the synthesis of prostaglandin analogues | |
| ES471349A1 (es) | Un procedimiento para la preparacion de un compuesto de pi- rrolidona | |
| IE42411L (en) | Trimethylsilyl acetylene derivatives | |
| US4068083A (en) | 2,2-Difluoro-13,14-dihydro-PGE1 analogs | |
| US4065628A (en) | 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGE, compounds | |
| US4113964A (en) | 13,14-Didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF1 α compounds | |
| US4151359A (en) | 11-Deoxy-17-phenyl-13,14-dihydro-PGE2 compounds | |
| US4212987A (en) | 2,2-Difluoro-PGE1 analogs | |
| GB1456511A (en) | P-biphenylyl esters of 15-substituted-16,17,18,19,20-pentanor prostaglandins | |
| US4051160A (en) | Cis-4,5-didehydro-11-deoxy-13,14-dihydro-PG compounds | |
| US4160102A (en) | ω-Aryl-inter-oxa-9-deoxy-PGD1 compounds | |
| US4212986A (en) | 2,2-Difluoro-PGE2 analogs | |
| US4061866A (en) | 2,2-Difluoro-13,14-dihydro-PGF1 analogs | |
| US4207420A (en) | 2,2-Difluoro-PGF1 analogs | |
| US4081594A (en) | Unsaturated bicyclic lactone intermediates for preparing pgc-type compounds | |
| US4337338A (en) | 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy-6-iodo-PGF1 amides | |
| GB1508925A (en) | 1,5-inter-(2,5-thienylene)-2,3,4,17,18,19,20-heptanorprostaglandins | |
| US4209637A (en) | 2,2-Difluoro-PGF2 analogs | |
| US4168384A (en) | ω-Aryl-inter-phenylene-12,13(e)-didehydro-13,14-dihydro-PGD1 compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |